(HealthDay)—A structured surveillance program for high-risk melanoma patients can be scaled and successfully replicated even in a primary care skin cancer clinic, according to a study published online March 17 in JAMA Dermatology.
Mar 23, 2021
0
2
(HealthDay)—For patients with in-hospital acute kidney injury (AKI), those with COVID-19-associated AKI have a greater rate of decrease in the estimated glomerular filtration rate (eGFR) after discharge, according to a ...
Mar 11, 2021
0
4
(HealthDay)—Tirbanibulin is superior to vehicle at two months for the treatment of actinic keratosis, but almost half of patients who had a complete response experienced recurrence of lesions at one year, according to a ...
Feb 11, 2021
0
1
(HealthDay)—For moderate-to-severe plaque psoriasis, bimekizumab is more efficacious than ustekinumab and placebo, according to a study published in the Feb. 6 issue of The Lancet.
Feb 5, 2021
0
2
(HealthDay)—Taken every other day, rimegepant demonstrates efficacy for the preventive treatment of migraine, according to a study published online Dec. 15 in The Lancet.
Dec 21, 2020
0
6
(HealthDay)—U.S. nephrology trainees report moderate and low confidence for peritoneal dialysis (PD) and home hemodialysis (HHD), respectively, according to a study published online Nov. 16 in the American Journal of Kidney ...
Nov 23, 2020
0
1
(HealthDay)—Vosoritide increases bone growth velocity in children with achondroplasia, the most common form of dwarfism, according to a study recently published in The Lancet.
Oct 27, 2020
0
2
(HealthDay)—For men with nonmetastatic, castration-resistant prostate cancer, the risk for death is significantly lower for those receiving darolutamide versus placebo, according to a study published in the Sept. 10 issue ...
Sep 15, 2020
0
3
(HealthDay)—A metabolomics screening tool may detect more than 50 percent of individuals with autism spectrum disorder (ASD), according to a study published online June 18 in Autism Research.
Jul 27, 2020
0
5
(HealthDay)—For patients with transfusion-dependent β-thalassemia, significantly more have a reduction in transfusion burden with receipt of luspatercept versus placebo, according to a study published in the March 26 issue ...
Mar 26, 2020
0
0
